Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gelteq (GELS) Liabilities and Shareholders Equity (2023 - 2025)

Gelteq has reported Liabilities and Shareholders Equity over the past 3 years, most recently at $13.8 million for Q2 2025.

  • For Q2 2025, Liabilities and Shareholders Equity rose 0.54% year-over-year to $13.8 million; the TTM value through Jun 2025 reached $58.9 million, changed N/A, while the annual FY2025 figure was $13.8 million, 0.54% up from the prior year.
  • Liabilities and Shareholders Equity for Q2 2025 was $13.8 million at Gelteq, down from $16.4 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $16.4 million in Q4 2024 and troughed at $13.7 million in Q2 2024.
  • A 3-year average of $14.7 million and a median of $14.4 million in 2023 define the central range for Liabilities and Shareholders Equity.
  • Biggest five-year swings in Liabilities and Shareholders Equity: dropped 9.01% in 2024 and later increased 0.54% in 2025.
  • Year by year, Liabilities and Shareholders Equity stood at $15.0 million in 2023, then rose by 9.24% to $16.4 million in 2024, then dropped by 16.26% to $13.8 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for GELS at $13.8 million in Q2 2025, $16.4 million in Q4 2024, and $13.7 million in Q2 2024.